UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

p53 Gene and Protein Status: The Role of p53 Alterations in Predicting Outcome in Patients With Bladder Cancer

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5352-5358

2007

Link zum Volltext

Verfügbarkeit prüfen

A sensitive and accurate test for simultaneous detection of 36 BRAF and NRAS mutations

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24153-e24153

2018

Link zum Volltext

Verfügbarkeit prüfen

TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy

Haematologica (Roma), 2013-05, Vol.98 (5), p.e59-e61

2013

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy : Molecular signatures of chemoresistant tumors

International journal of oncology, 2006-07, Vol.29 (1), p.5-24

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5156: Multiplexed EGFR mutation detection with C797S and T790M allelic context using six-color digital PCR

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5156-5156

2022

Link zum Volltext

Verfügbarkeit prüfen

TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods

Tumor biology, 2015-05, Vol.36 (5), p.3371-3380

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: Correlation with clinical outcome and gene expression profiling

Genes chromosomes & cancer, 2011-04, Vol.50 (4), p.263-274

2011

Link zum Volltext

Verfügbarkeit prüfen

Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches

Blood, 2012-11, Vol.120 (21), p.3911-3911

2012

Link zum Volltext

Verfügbarkeit prüfen

Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues

Applied immunohistochemistry & molecular morphology, 2002-09, Vol.10 (3), p.269

2002

Link zum Volltext

Verfügbarkeit prüfen

Screening for TP53 Mutations Identifies Chronic Lymphocytic Leukemia Patients with Rapid Disease Progression

Blood, 2007-11, Vol.110 (11), p.490-490

2007

Link zum Volltext

Verfügbarkeit prüfen

TP53 Mutations and Outcome After Fludarabine and Cyclophosphamide (FC) or FC Plus Rituximab (FCR) in the CLL8 Trial of the GCLLSG

Blood, 2009-11, Vol.114 (22), p.1267-1267

2009

Link zum Volltext

Verfügbarkeit prüfen

17p Deletion in CLL: Detailed Analysis of TP53 Mutations, Alternative Mechanisms of p53 Inactivation, Clone Size and Clonal Evolution

Blood, 2008-11, Vol.112 (11), p.782-782

2008

Link zum Volltext

Verfügbarkeit prüfen

High Frequency of P53 Mutations Detected by a Microarray Resequencing Assay, the AmpliChip P53 Test, in AML with a Complex Aberrant Karyotype

Blood, 2006-11, Vol.108 (11), p.4341-4341

2006

Link zum Volltext

Verfügbarkeit prüfen

Strong p53 Expression Is an Independent Predictor of Outcome in De Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Either CHOP or CHOP-R

Blood, 2006-11, Vol.108 (11), p.812-812

2006

Link zum Volltext

Verfügbarkeit prüfen

p53 Gene and Protein Status : The Role of p 53 Alterations in Predicting Outcome in Patients With Bladder Cancer

Journal of clinical oncology, 2007, Vol.25 (34), p.5352-5358

2007

Link zum Volltext

Verfügbarkeit prüfen

TP53 Abnormalities in Chronic Lymphocytic Leukemia Exhibit a Disease Specific Profile: Meta-Analysis of 270 Mutations

Blood, 2008-11, Vol.112 (11), p.2077-2077

2008

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the IFN-γ cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis

Leukemia research, 2000-07, Vol.24 (7), p.611-621

2000

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study

Neurology, 2017-12, Vol.89 (24), p.2455

2017

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal effectiveness of a woman-led, nurse delivered health promotion intervention for women who have experienced intimate partner violence: iHEAL randomized controlled trial

BMC public health, 2024-02, Vol.24 (1), p.398-398

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

p53 Gene and Protein Status: The Role of p53 Alterations in Predicting Outcome in Patients With Bladder Cancer

Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial

A sensitive and accurate test for simultaneous detection of 36 BRAF and NRAS mutations

TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy

Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy : Molecular signatures of chemoresistant tumors

Abstract 5156: Multiplexed EGFR mutation detection with C797S and T790M allelic context using six-color digital PCR

Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients

TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods

Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: Correlation with clinical outcome and gene expression profiling

Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches

Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial

Low Expression of MiR-34a in Previously Treated Chronic Lymphocytic Leukemia Patients Is Limited to Patients with a Complete Disruption of TP53 Function and Does Not Correlate with MDM2 SNP309

Disruption of TP53 function by Point Mutations and Deletions Is Associated with An Increased Risk of Disease Progression within Previously Treated, Relapsed Chronic Lymphocytic Leukemia Patients

Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues

Screening for TP53 Mutations Identifies Chronic Lymphocytic Leukemia Patients with Rapid Disease Progression

TP53 Mutations and Outcome After Fludarabine and Cyclophosphamide (FC) or FC Plus Rituximab (FCR) in the CLL8 Trial of the GCLLSG

17p Deletion in CLL: Detailed Analysis of TP53 Mutations, Alternative Mechanisms of p53 Inactivation, Clone Size and Clonal Evolution

High Frequency of P53 Mutations Detected by a Microarray Resequencing Assay, the AmpliChip P53 Test, in AML with a Complex Aberrant Karyotype

Strong p53 Expression Is an Independent Predictor of Outcome in De Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Either CHOP or CHOP-R

p53 Gene and Protein Status : The Role of p 53 Alterations in Predicting Outcome in Patients With Bladder Cancer

Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study

TP53 Abnormalities in Chronic Lymphocytic Leukemia Exhibit a Disease Specific Profile: Meta-Analysis of 270 Mutations

Disruption of the IFN-γ cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study

Longitudinal effectiveness of a woman-led, nurse delivered health promotion intervention for women who have experienced intimate partner violence: iHEAL randomized controlled trial

Suchergebnisse filtern